Galera Therapeutics (GRTX) Short Interest Ratio & Short Volume $0.03 0.00 (-4.41%) As of 07/1/2025 03:50 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Galera Therapeutics Short Interest DataGalera Therapeutics (GRTX) has a short interest of 7,400 shares, representing 0.02% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 95,497 shares to cover all short positions.Current Short Interest7,400 sharesPrevious Short Interest7,400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$199.80Short Interest Ratio0.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares75,462,000 sharesShort Percent of Float0.02%Today's Trading Volume89,589 sharesAverage Trading Volume95,497 sharesToday's Volume Vs. Average94% Short Selling Galera Therapeutics? Sign up to receive the latest short interest report for Galera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGRTX Short Interest Over TimeGRTX Days to Cover Over TimeGRTX Percentage of Float Shorted Over Time Galera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20257,400 shares $199.80 No Change0.0%0.1 $0.03 5/31/20257,400 shares $173.90 No Change0.0%0.1 $0.02 5/15/20257,400 shares $177.60 No ChangeN/A0.1 $0.02 4/30/20257,400 shares $163.54 No ChangeN/A0.1 $0.02 4/15/20257,400 shares $199.80 No ChangeN/A0 $0.03 3/14/20257,400 shares $251.60 No ChangeN/A0.1 $0.03 2/28/20257,400 shares $283.42 -3.9%N/A0.1 $0.04 2/14/20257,700 shares $323.40 -79.0%N/A0 $0.04 1/31/202536,600 shares $1.56 thousand -3.2%N/A0.4 $0.04 1/15/202537,800 shares $1.74 thousand +410.8%N/A0 $0.05 Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/31/20241,910,000 shares $410.84 thousand -9.9%5.5%1.1 $0.22 5/15/20242,120,000 shares $402.80 thousand -24.0%6.1%1 $0.19 4/30/20242,790,000 shares $519.78 thousand +4.9%7.3%1.4 $0.19 4/15/20242,660,000 shares $406.71 thousand +50.3%6.5%1.4 $0.15 3/31/20241,770,000 shares $247.80 thousand -36.8%4.1%0.7 $0.14 3/15/20242,800,000 shares $591.36 thousand -45.0%7.3%1.4 $0.21 2/29/20245,090,000 shares $1.24 million +51.5%13.3%2.5 $0.24 2/15/20243,360,000 shares $613.20 thousand -4.0%8.6%1.7 $0.18 1/31/20243,500,000 shares $626.50 thousand -24.6%9.9%1.9 $0.18 1/15/20244,640,000 shares $997.60 thousand +197.4%13.1%1.4 $0.22 12/31/20231,560,000 shares $226.82 thousand +12.2%3.7%0.4 $0.15 12/15/20231,390,000 shares $190.43 thousand +1.5%3.3%0.4 $0.14 11/30/20231,370,000 shares $195.23 thousand -24.7%3.5%0.3 $0.14 11/15/20231,820,000 shares $263.17 thousand -36.6%4.5%0.4 $0.14 10/31/20232,870,000 shares $278.68 thousand -1.0%8.0%0.5 $0.10 10/15/20232,900,000 shares $553.90 thousand -18.3%8.1%0.6 $0.19 9/30/20233,550,000 shares $621.61 thousand +73.2%9.9%1 $0.18 9/15/20232,050,000 shares $386.63 thousand -15.6%5.7%0.6 $0.19 8/31/20232,430,000 shares $510.30 thousand -27.7%6.8%1 $0.21 8/15/20233,360,000 shares $906.86 thousand +128.6%9.4%1.4 $0.27 7/31/20231,470,000 shares $3.62 million +32.4%4.2%1.7 $2.46 7/15/20231,110,000 shares $3.05 million +12.8%3.2%1.6 $2.75 6/30/2023984,000 shares $3.07 million +11.8%2.9%1.6 $3.12 6/15/2023880,500 shares $2.98 million +8.4%2.6%1.4 $3.39 5/31/2023812,600 shares $2.49 million -1.7%2.4%1.2 $3.07 5/15/2023826,900 shares $2.63 million No Change2.4%1.1 $3.18 10/31/2022610,400 shares $885.08 thousand +17.4%3.4%5 $1.45 10/15/2022519,800 shares $805.69 thousand -2.5%2.9%6 $1.55 9/30/2022533,100 shares $927.59 thousand +4.5%2.9%6.1 $1.74 9/15/2022510,200 shares $954.07 thousand +8.5%2.8%5.4 $1.87Dalio heeds Buffett’s warning… [$319 million stake in gold] (Ad)Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks. Get Garrett’s Top Four gold picks now — before the world’s greatest investor pulls the trigger. 8/31/2022470,100 shares $629.93 thousand +2.0%2.6%5.1 $1.34 8/15/2022460,900 shares $672.91 thousand -4.9%2.5%5.5 $1.46 7/31/2022484,800 shares $562.37 thousand -0.6%2.7%4.7 $1.16 7/15/2022487,900 shares $585.48 thousand -8.7%2.7%3.7 $1.20 6/30/2022534,400 shares $694.72 thousand -4.0%3.0%3.8 $1.30 6/15/2022556,700 shares $823.92 thousand -6.2%3.1%3.8 $1.48 5/31/2022593,500 shares $949.60 thousand +11.4%3.3%3.3 $1.60 5/15/2022533,000 shares $804.83 thousand -17.5%2.9%2.4 $1.51 4/30/2022645,900 shares $1.09 million +21.0%3.6%2.6 $1.69 4/15/2022534,000 shares $1.14 million +1.9%3.0%1.7 $2.13 3/31/2022524,200 shares $1.25 million -8.0%N/A0 $2.38 3/15/2022569,800 shares $1.20 million -11.1%3.2%0.2 $2.10 2/28/2022640,700 shares $1.44 million +115.7%3.6%0.1 $2.24 2/15/2022297,000 shares $694.98 thousand +93.7%1.7%0 $2.34 1/31/2022153,300 shares $420.04 thousand -73.6%1.4%0 $2.74 1/15/2022580,700 shares $2.00 million -71.0%N/A0 $3.44 12/31/20212,000,000 shares $9.18 million +226.7%18.0%0.2 $4.59 12/15/2021612,100 shares $1.78 million -17.2%5.5%0.1 $2.90 11/30/2021739,100 shares $975.61 thousand +14.6%7.1%0.2 $1.32 11/15/2021645,000 shares $1.08 million -57.6%6.2%0.2 $1.68 10/29/20211,520,000 shares $2.84 million +814.0%15.2%0.6 $1.87 10/15/2021166,300 shares $1.30 million +8.5%1.7%0.2 $7.81 9/30/2021153,300 shares $1.24 million -3.1%1.5%2.2 $8.10 9/15/2021158,200 shares $1.14 million -11.9%1.5%1.7 $7.18 8/31/2021179,600 shares $1.61 million -4.5%1.7%1.6 $8.96 8/13/2021188,100 shares $1.56 million -16.1%1.8%1.5 $8.30 7/30/2021224,200 shares $1.88 million -15.6%2.1%1.5 $8.38 7/15/2021265,600 shares $2.48 million -3.6%2.5%0.4 $9.34 6/30/2021275,500 shares $2.71 million -43.9%2.6%0.4 $9.83 6/15/2021490,900 shares $4.40 million +0.9%4.7%0.8 $8.96 5/28/2021486,600 shares $4.17 million -1.5%4.6%0.8 $8.57 5/14/2021494,000 shares $3.52 million +51.2%4.8%0.9 $7.12 4/30/2021326,700 shares $2.65 million +103.4%3.4%0.6 $8.12 4/15/2021160,600 shares $1.21 million +4.8%N/A0 $7.52 3/31/2021153,200 shares $1.28 million +6.0%1.6%2.3 $8.35 3/15/2021144,500 shares $1.59 million -2.0%1.5%2.2 $11.00 2/26/2021147,500 shares $1.55 million +13.5%1.5%2.1 $10.48 2/12/2021130,000 shares $1.54 million +12.9%1.3%1.9 $11.84 1/29/2021115,200 shares $1.22 million +25.6%1.4%1.7 $10.63 1/15/202191,700 shares $917.92 thousand -18.7%1.1%1 $10.01 12/31/2020112,800 shares $1.22 million -5.7%1.4%1.5 $10.79 12/15/2020119,600 shares $1.29 million -1.0%1.4%1.3 $10.80 11/30/2020120,800 shares $1.35 million -10.8%1.5%1.5 $11.21 11/15/2020135,400 shares $1.38 million -4.1%1.6%1.8 $10.20 10/30/2020141,200 shares $1.24 million +63.8%1.7%2 $8.78 10/15/202086,200 shares $1.08 million -6.6%0.9%1.4 $12.50 9/30/202092,300 shares $834.39 thousand -11.0%1.0%2.2 $9.04 9/15/2020103,700 shares $852.41 thousand -8.2%1.1%2.5 $8.22 8/31/2020112,900 shares $881.75 thousand -2.0%1.2%1.7 $7.81 8/14/2020115,200 shares $899.71 thousand -1.5%1.2%1.6 $7.81Dalio heeds Buffett’s warning… [$319 million stake in gold] (Ad)Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks. Get Garrett’s Top Four gold picks now — before the world’s greatest investor pulls the trigger. 7/31/2020116,900 shares $813.62 thousand -7.8%1.2%1.6 $6.96 7/15/2020126,800 shares $997.92 thousand +4.4%1.3%1.8 $7.87 GRTX Short Interest - Frequently Asked Questions What is Galera Therapeutics' current short interest? Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 7,400 shares of GRTX short. 0.02% of Galera Therapeutics' shares are currently sold short. Learn More on Galera Therapeutics' current short interest. What is a good short interest percentage for Galera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Galera Therapeutics' floating shares are currently sold short. How does Galera Therapeutics' short interest compare to its competitors? 0.02% of Galera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Galera Therapeutics: Calidi Biotherapeutics, Inc. (1.23%), Biomerica, Inc. (2.31%), Chromocell Therapeutics Co. (8.70%), CEL-SCI Co. (5.24%), Nuvilex Inc. (0.35%), Cyclacel Pharmaceuticals, Inc. (2.67%), Indaptus Therapeutics, Inc. (5.80%), Alaunos Therapeutics, Inc. (3.03%), Omega Therapeutics, Inc. (26.99%), AIM ImmunoTech Inc. (414.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Galera Therapeutics stock? Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. GRTX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galera Therapeutics? A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further. How often is Galera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies CLDI Short Interest BMRA Short Interest CHRO Short Interest CVM Short Interest PMCB Short Interest CYCC Short Interest INDP Short Interest TCRT Short Interest OMGA Short Interest AIM Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRTX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRTX Stock Alerts